Justin Daniel Salciccioli, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
European Union | 11 | 2022 | 157 | 1.990 |
Why?
|
Out-of-Hospital Cardiac Arrest | 12 | 2019 | 299 | 1.660 |
Why?
|
Cardiopulmonary Resuscitation | 8 | 2020 | 888 | 1.140 |
Why?
|
Heart Arrest | 9 | 2020 | 1351 | 1.000 |
Why?
|
Thiamine | 3 | 2019 | 136 | 0.910 |
Why?
|
Neuromuscular Blockade | 2 | 2013 | 147 | 0.900 |
Why?
|
Pellagra | 1 | 2019 | 9 | 0.780 |
Why?
|
Niacin | 1 | 2019 | 113 | 0.720 |
Why?
|
Vitamin B Complex | 2 | 2019 | 287 | 0.670 |
Why?
|
Tongue | 1 | 2019 | 402 | 0.600 |
Why?
|
Life Support Care | 1 | 2016 | 219 | 0.520 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 684 | 0.480 |
Why?
|
School Health Services | 1 | 2017 | 378 | 0.480 |
Why?
|
Pseudomonas Infections | 1 | 2017 | 620 | 0.460 |
Why?
|
Lymphocyte Count | 1 | 2015 | 813 | 0.460 |
Why?
|
Diarrhea | 1 | 2019 | 1354 | 0.450 |
Why?
|
Hospital Mortality | 12 | 2022 | 5095 | 0.440 |
Why?
|
Immunocompromised Host | 1 | 2017 | 882 | 0.430 |
Why?
|
Pseudomonas aeruginosa | 1 | 2017 | 1269 | 0.370 |
Why?
|
Lactic Acid | 4 | 2019 | 1126 | 0.370 |
Why?
|
Hydroxyl Radical | 1 | 2008 | 77 | 0.360 |
Why?
|
Europe | 8 | 2022 | 3104 | 0.360 |
Why?
|
Peroxides | 1 | 2008 | 69 | 0.360 |
Why?
|
Databases, Factual | 6 | 2021 | 7763 | 0.350 |
Why?
|
Free Radical Scavengers | 1 | 2008 | 230 | 0.330 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3014 | 0.330 |
Why?
|
Stilbenes | 1 | 2008 | 199 | 0.320 |
Why?
|
World Health Organization | 5 | 2022 | 1261 | 0.320 |
Why?
|
Prealbumin | 1 | 2008 | 209 | 0.310 |
Why?
|
Lung Diseases | 1 | 2017 | 1889 | 0.310 |
Why?
|
Pneumonia | 1 | 2018 | 2080 | 0.300 |
Why?
|
Education, Medical | 2 | 2017 | 1683 | 0.290 |
Why?
|
Peripheral Arterial Disease | 3 | 2021 | 1206 | 0.280 |
Why?
|
Hypothermia, Induced | 4 | 2014 | 715 | 0.280 |
Why?
|
Critical Illness | 2 | 2015 | 2496 | 0.280 |
Why?
|
Myocardial Ischemia | 3 | 2022 | 2114 | 0.270 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2017 | 2100 | 0.270 |
Why?
|
Mortality | 9 | 2022 | 2732 | 0.250 |
Why?
|
Asthma | 1 | 2021 | 5850 | 0.230 |
Why?
|
Shock, Septic | 3 | 2014 | 718 | 0.230 |
Why?
|
APACHE | 2 | 2012 | 270 | 0.220 |
Why?
|
Intensive Care Units | 6 | 2021 | 3418 | 0.220 |
Why?
|
Female | 52 | 2022 | 375205 | 0.220 |
Why?
|
Cerebrovascular Disorders | 2 | 2021 | 1508 | 0.220 |
Why?
|
Severity of Illness Index | 4 | 2012 | 16008 | 0.220 |
Why?
|
Quality-Adjusted Life Years | 3 | 2022 | 1592 | 0.220 |
Why?
|
Neutrophils | 1 | 2015 | 3867 | 0.220 |
Why?
|
Acidosis, Lactic | 2 | 2013 | 128 | 0.210 |
Why?
|
Stroke | 2 | 2022 | 9256 | 0.210 |
Why?
|
Vasoconstrictor Agents | 3 | 2019 | 631 | 0.210 |
Why?
|
Male | 49 | 2022 | 349524 | 0.200 |
Why?
|
Humans | 65 | 2022 | 708843 | 0.200 |
Why?
|
Ubiquinone | 2 | 2012 | 195 | 0.200 |
Why?
|
Weather | 1 | 2020 | 211 | 0.190 |
Why?
|
Body Temperature | 2 | 2014 | 781 | 0.190 |
Why?
|
Incidence | 10 | 2022 | 20320 | 0.190 |
Why?
|
Aortic Rupture | 1 | 2022 | 310 | 0.190 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1121 | 0.180 |
Why?
|
Cytochromes c | 1 | 2019 | 184 | 0.180 |
Why?
|
Stockings, Compression | 1 | 2018 | 36 | 0.180 |
Why?
|
Atrial Flutter | 1 | 2021 | 248 | 0.180 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7487 | 0.180 |
Why?
|
Leukocyte Count | 2 | 2015 | 1670 | 0.180 |
Why?
|
Endocarditis, Bacterial | 1 | 2022 | 434 | 0.170 |
Why?
|
Endocarditis | 1 | 2022 | 323 | 0.170 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 614 | 0.170 |
Why?
|
Piperacillin | 1 | 2017 | 43 | 0.170 |
Why?
|
Penicillanic Acid | 1 | 2017 | 35 | 0.170 |
Why?
|
Brain Edema | 2 | 2014 | 616 | 0.160 |
Why?
|
Defibrillators | 1 | 2017 | 34 | 0.160 |
Why?
|
London | 1 | 2017 | 234 | 0.160 |
Why?
|
Aneurysm, Dissecting | 1 | 2022 | 647 | 0.150 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2022 | 621 | 0.150 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2017 | 106 | 0.150 |
Why?
|
Emergency Medical Services | 3 | 2016 | 1746 | 0.140 |
Why?
|
Medical Audit | 1 | 2017 | 475 | 0.140 |
Why?
|
Amputation | 1 | 2020 | 791 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 791 | 0.140 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 548 | 0.130 |
Why?
|
Tissue and Organ Procurement | 1 | 2022 | 850 | 0.130 |
Why?
|
Treatment Outcome | 14 | 2022 | 61932 | 0.130 |
Why?
|
Predictive Value of Tests | 8 | 2015 | 15252 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2022 | 1154 | 0.130 |
Why?
|
Middle Aged | 30 | 2021 | 213752 | 0.130 |
Why?
|
Rewarming | 1 | 2013 | 62 | 0.120 |
Why?
|
Atrial Fibrillation | 2 | 2021 | 4454 | 0.120 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2022 | 1312 | 0.120 |
Why?
|
Lactates | 1 | 2013 | 410 | 0.120 |
Why?
|
Ventricular Function | 1 | 2014 | 427 | 0.120 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2018 | 429 | 0.120 |
Why?
|
Adrenergic beta-Agonists | 1 | 2014 | 359 | 0.120 |
Why?
|
Aged | 26 | 2021 | 161488 | 0.110 |
Why?
|
Lower Extremity | 1 | 2020 | 1041 | 0.110 |
Why?
|
Abdomen | 1 | 2018 | 1094 | 0.110 |
Why?
|
Austria | 2 | 2022 | 180 | 0.110 |
Why?
|
Czech Republic | 2 | 2022 | 53 | 0.110 |
Why?
|
Myoclonus | 1 | 2011 | 99 | 0.110 |
Why?
|
Sodium | 1 | 2017 | 1637 | 0.110 |
Why?
|
Pneumonia, Bacterial | 1 | 2014 | 314 | 0.110 |
Why?
|
Nervous System Diseases | 2 | 2012 | 1630 | 0.100 |
Why?
|
Respiratory Rate | 1 | 2012 | 160 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 1652 | 0.100 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2020 | 1179 | 0.100 |
Why?
|
Prospective Studies | 11 | 2019 | 50597 | 0.100 |
Why?
|
Epinephrine | 1 | 2014 | 807 | 0.100 |
Why?
|
Cerebral Hemorrhage | 1 | 2022 | 2518 | 0.100 |
Why?
|
Norway | 2 | 2022 | 456 | 0.100 |
Why?
|
ROC Curve | 3 | 2012 | 3518 | 0.100 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 980 | 0.090 |
Why?
|
Vertigo | 1 | 2011 | 192 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 1962 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2402 | 0.090 |
Why?
|
Aged, 80 and over | 14 | 2020 | 58184 | 0.090 |
Why?
|
Retrospective Studies | 18 | 2022 | 71483 | 0.090 |
Why?
|
Health Status | 1 | 2022 | 4015 | 0.090 |
Why?
|
Regression Analysis | 4 | 2021 | 6451 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2014 | 987 | 0.090 |
Why?
|
Diabetic Ketoacidosis | 1 | 2011 | 224 | 0.090 |
Why?
|
Logistic Models | 5 | 2017 | 13468 | 0.090 |
Why?
|
Endovascular Procedures | 1 | 2022 | 1959 | 0.090 |
Why?
|
Developed Countries | 2 | 2022 | 402 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2022 | 2219 | 0.090 |
Why?
|
United States | 10 | 2022 | 67165 | 0.090 |
Why?
|
Hydrogen Bonding | 1 | 2008 | 296 | 0.090 |
Why?
|
Prevalence | 3 | 2022 | 14712 | 0.090 |
Why?
|
Urinary Tract Infections | 1 | 2014 | 781 | 0.090 |
Why?
|
Data Collection | 2 | 2022 | 3276 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1551 | 0.090 |
Why?
|
Career Choice | 1 | 2014 | 743 | 0.090 |
Why?
|
Schools | 1 | 2017 | 1361 | 0.080 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 2129 | 0.080 |
Why?
|
Positive-Pressure Respiration | 1 | 2012 | 591 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2018 | 1278 | 0.080 |
Why?
|
Oxygen Consumption | 1 | 2014 | 1928 | 0.080 |
Why?
|
Crystallization | 1 | 2008 | 529 | 0.080 |
Why?
|
Cohort Studies | 7 | 2016 | 39292 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2022 | 4116 | 0.080 |
Why?
|
Registries | 4 | 2021 | 7989 | 0.080 |
Why?
|
Recurrence | 1 | 2019 | 8255 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 6991 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1156 | 0.080 |
Why?
|
Bacteremia | 2 | 2012 | 968 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2018 | 1537 | 0.080 |
Why?
|
Kidney Neoplasms | 1 | 2022 | 3970 | 0.070 |
Why?
|
Risk Factors | 6 | 2022 | 69553 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2014 | 988 | 0.070 |
Why?
|
Fever | 1 | 2013 | 1588 | 0.070 |
Why?
|
England | 2 | 2017 | 513 | 0.070 |
Why?
|
Time Factors | 5 | 2020 | 41038 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1880 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2017 | 20308 | 0.070 |
Why?
|
Liver | 1 | 2020 | 7622 | 0.070 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 802 | 0.060 |
Why?
|
Molecular Structure | 1 | 2008 | 1971 | 0.060 |
Why?
|
Crystallography, X-Ray | 1 | 2008 | 2008 | 0.060 |
Why?
|
Adult | 13 | 2022 | 211041 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3558 | 0.060 |
Why?
|
Emergency Service, Hospital | 5 | 2014 | 7428 | 0.060 |
Why?
|
General Surgery | 1 | 2014 | 1645 | 0.060 |
Why?
|
Oxygen | 1 | 2014 | 4150 | 0.060 |
Why?
|
Vitamins | 1 | 2011 | 1466 | 0.060 |
Why?
|
Luxembourg | 1 | 2021 | 1 | 0.060 |
Why?
|
Students, Medical | 1 | 2014 | 1740 | 0.060 |
Why?
|
Bulgaria | 1 | 2021 | 22 | 0.060 |
Why?
|
Melanoma | 1 | 2020 | 5194 | 0.060 |
Why?
|
Stroke Volume | 1 | 2014 | 4522 | 0.050 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2010 | 1080 | 0.050 |
Why?
|
Ireland | 1 | 2021 | 155 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 9644 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13274 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5266 | 0.050 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2748 | 0.050 |
Why?
|
Recovery of Function | 1 | 2011 | 2950 | 0.050 |
Why?
|
Gross Domestic Product | 1 | 2020 | 65 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2016 | 4173 | 0.050 |
Why?
|
Coronary Artery Bypass | 1 | 2010 | 2376 | 0.050 |
Why?
|
Hospitals, Urban | 2 | 2012 | 514 | 0.050 |
Why?
|
Patient Discharge | 3 | 2020 | 2980 | 0.050 |
Why?
|
Survival Analysis | 4 | 2014 | 10507 | 0.050 |
Why?
|
Germany | 1 | 2021 | 791 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 4810 | 0.040 |
Why?
|
Sunlight | 1 | 2020 | 324 | 0.040 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2018 | 20 | 0.040 |
Why?
|
Hospitals | 2 | 2022 | 3290 | 0.040 |
Why?
|
Sweden | 1 | 2021 | 1290 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 10857 | 0.040 |
Why?
|
Length of Stay | 1 | 2011 | 6257 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2011 | 3260 | 0.040 |
Why?
|
Morbidity | 1 | 2022 | 1690 | 0.040 |
Why?
|
Cytokines | 1 | 2012 | 7189 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 23284 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2021 | 19800 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7644 | 0.040 |
Why?
|
Australia | 1 | 2020 | 1276 | 0.040 |
Why?
|
Northern Ireland | 1 | 2016 | 39 | 0.040 |
Why?
|
Wales | 1 | 2016 | 83 | 0.040 |
Why?
|
Odds Ratio | 3 | 2017 | 9754 | 0.040 |
Why?
|
Prognosis | 5 | 2019 | 28919 | 0.040 |
Why?
|
Scotland | 1 | 2016 | 147 | 0.040 |
Why?
|
State Medicine | 1 | 2017 | 202 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1061 | 0.040 |
Why?
|
Sex Distribution | 1 | 2020 | 2328 | 0.030 |
Why?
|
Adolescent | 3 | 2020 | 84718 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2144 | 0.030 |
Why?
|
Age Distribution | 1 | 2020 | 2876 | 0.030 |
Why?
|
Ontario | 1 | 2014 | 358 | 0.030 |
Why?
|
Databases as Topic | 1 | 2016 | 480 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2014 | 1472 | 0.030 |
Why?
|
Age Factors | 3 | 2015 | 18712 | 0.030 |
Why?
|
Disabled Persons | 1 | 2021 | 1154 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2021 | 1510 | 0.030 |
Why?
|
Graft Survival | 1 | 2022 | 3767 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1843 | 0.030 |
Why?
|
Inflammation | 1 | 2011 | 10019 | 0.030 |
Why?
|
Cost of Illness | 1 | 2021 | 1820 | 0.030 |
Why?
|
Electric Countershock | 1 | 2014 | 512 | 0.030 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 466 | 0.030 |
Why?
|
Acute Disease | 2 | 2012 | 7158 | 0.030 |
Why?
|
Pilot Projects | 2 | 2014 | 7994 | 0.030 |
Why?
|
Hospitals, University | 1 | 2012 | 582 | 0.020 |
Why?
|
Tidal Volume | 1 | 2012 | 479 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 5045 | 0.020 |
Why?
|
Graft Rejection | 1 | 2022 | 4408 | 0.020 |
Why?
|
Child | 1 | 2017 | 73636 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14836 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 724 | 0.020 |
Why?
|
Calibration | 1 | 2011 | 802 | 0.020 |
Why?
|
Observation | 1 | 2010 | 310 | 0.020 |
Why?
|
Young Adult | 4 | 2016 | 55940 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12447 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39038 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 2865 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 20172 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15053 | 0.020 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2010 | 326 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1688 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2920 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8896 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2680 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5182 | 0.020 |
Why?
|
Cross Infection | 1 | 2014 | 1412 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2020 | 2996 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2144 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 5041 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 2473 | 0.020 |
Why?
|
Liver Diseases | 1 | 2012 | 1246 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 11239 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2351 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 23020 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8712 | 0.010 |
Why?
|
Survivors | 1 | 2011 | 2149 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 13202 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10566 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10339 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2012 | 4266 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3097 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6497 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 10525 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2016 | 12183 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 34151 | 0.000 |
Why?
|